Non-Selective Beta-Adrenergic Blocker Propranolol: A Life Saving Drug for Hospitalized Patient with Traumatic Brain Injury in Intensive Care Unit
Abstract
Background: Traumatic Brain Injury (TBI) is the most common cause of death under the age of forty. This in turn results in intracranial injury in about 90% of the cases from least-income countries. The majority of patients admitted to the Intensive care Unit (ICU) had trauma which is managed by preventive strategies and to combat the secondary hit stimulated by the primary hit International guidelines have formed a protocol to be applied in patients with TBI for the better outcome and to increase the survival rate.
Objectives: The aim of this study was to determine the importance of beta-adrenergic blocker propranolol in patients admitted with TBI.
Methodology: The literature search was conducted to find recent articles related to the aim of the study to analyze the significance of beta-blocking agent propranolol in TBI.
Results: Paroxysmal Sympathetic Hyperactivity (PSH) occurs within 24 hours of TBI in patients with Glasgow Coma Scale (GCS ≤ 8). In patients who are agitated or in restlessness propranolol is the drug of choice to reduce hyperactivity. Several studies reported that using beta-adrenergic blocking agents decreases the mortality rate and current studies started focusing on the primary initiation of propranolol and also reported side-effects associated in TBI.
Conclusion: Early administration of Non-selective beta-adrenergic blocker propranolol will continue to be the standard prophylactic pharmacotherapeutic method as it limits the risk of sympathetic storming in high-risk patients with TBI.
Keywords: Traumatic Brain Injury (TBI), Propranolol, Beta-adrenergic blocker, Paroxysmal Sympathetic Hyperactivity (PSH).
Keywords:
Traumatic Brain Injury (TBI), Propranolol, Beta-adrenergic blocker, Paroxysmal Sympathetic Hyperactivity (PSH)DOI
https://doi.org/10.22270/jddt.v13i4.6025References
Corrigan JD, Selassie AW, Orman JA, etal.The epidemiology of traumatic brain injury. J Head Trauma Rehabil. 2010; 25(2):72-80. https://doi.org/10.1097/HTR.0b013e3181ccc8b4
Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018; 1-18.10.3171/2017.10. JNS17352
Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma.1993; 34:216-222. https://doi.org/10.1097/00005373-199302000-00006
Manley G, Knudson MM, MorabitoD, et al. Hypotension, hypoxia, and head injury: frequency, duration and consequences. Arch Surg. 2001; 136(10):1118-1123. https://doi.org/10.1001/archsurg.136.10.1118
CarneyN, et al. Guidelines for management of severe TBI, 4th edn.Available at: https://braintrauma.org/uploads/03/12/Guidelines_for_Management_of_Severe_TBI_4th_Edition.pdf.(accessed 11May 2017).
Koskinen LOD, Olivecrona M, Grande PO, et al. Severe traumatic brain injury management and clinical outcome using the Lund concept. Neuroscience. 2014; 283:245-255. https://doi.org/10.1016/j.neuroscience.2014.06.039
Alali AS, McCredie VA, Golan E, et al. Beta blockers for acute traumatic brain injury: a systematic review and metaanalysis. Neurocrit Care. 2014; 20:514. https://doi.org/10.1007/s12028-013-9903-5
Cotton BA, Snodgrass KB, Fleming SB, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma Injury Infect Crit Care.2007; 62(1):26-35. https://doi.org/10.1097/TA.0b013e31802d02d0
Ko A, Harada MY, Barmparas G, et al. Early propranolol after traumatic brain injury is associated with lower mortality. J Trauma Acute Care Surg.2016; 80(4):637-642. https://doi.org/10.1097/TA.0000000000000959
Dhillon NK, Inaba K, Salim A, et al. Beta blockers in critically ill patients with traumatic brain injury: results from a multicenter, prospective, observational American Association for the Surgery of Trauma study. J Trauma Acute Care Surg. 2018; 84(2):234-244. https://doi.org/10.1097/TA.0000000000001747
Mohseni S, Talving P, Wallin G, et al. Pre-injury betablockade is protective in isolated severe traumatic brain injury. J Trauma. 2014; 76(3):804-808. https://doi.org/10.1097/TA.0000000000000139
Kishner S, Augustin J, Strum S, et al. Post headinjury autonomic complications. Availableat: www.emedicine.com/pmr/topic108.htm.(accessed 8 November 2006).
Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL,Chestnut RM, et al. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma. 2007; 24 (1): S7 13.10.1089/neu.2007.9995
Arbabi S, Campion EM, Hemmila MR, et al. Beta blocker use is associated with improved outcomes in adult trauma patients. J Trauma.2007; 62:56 61. https://doi.org/10.1097/TA.0b013e31802d972b
Perkess I, Baguley IJ, Nott MT, M, et al. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol.2010; 68:126 35. https://doi.org/10.1002/ana.22066
Baguley IJ, Cameron ID, Green AM, et al. Pharmacological management of dysautonomia following traumatic brain injury. Brain Inj. 2004; 18:409-417. https://doi.org/10.1080/02699050310001645775
Boeve B, Wijdicka E, Benarroch E, at al. Paroxysmal sympathetic storms (diencephalic seizures) after diffuse axonal head injury. Mayo Clin Proc. 1998; 732:148-152. https://doi.org/10.1016/S0025-6196(11)63647-1
Lemke DM. Riding out the storm: sympathetic storming after traumatic brain injury. J NeurosciNurs. 2003; 36:4-9. https://doi.org/10.1097/01376517-200402000-00002
Hinson HE, Sheth KN. Manifestations of the hyperadrenergic state after acute brain injury. CurrOpinCrit Care. 2012; 18:139 45. https://doi.org/10.1097/MCC.0b013e3283513290
Heffernan DS, Inaba K, Arbabi S, at al. Sympathetic hyperactivity after traumatic brain injury and the role of beta blocker therapy. J Trauma. 2010; 69:1602 9. https://doi.org/10.1097/TA.0b013e3181f2d3e8
Ley EJ, Park R, Dagliyan G, etal.In vivo effect of propranolol dose and timing on cerebral perfusion aftertraumatic brain injury. J Trauma. 2010; 68:353 6. https://doi.org/10.1097/TA.0b013e3181c8269a
Christin L, Ravussin E, Bogardus C, at al. The effect of propranolol on free fatty acid mobilization and resting metabolic rate. Metabolism. 1989; 38:439-44. https://doi.org/10.1016/0026-0495(89)90195-9
Welle S, Schwartz RG, Statt M, et al. Reduced metabolic rate during β-adrenergic blockade in humans.Metabolism. 1991; 40:619-22. https://doi.org/10.1016/0026-0495(91)90053-Y
Do D, Sheen VL, Bromfield E, et al. Treatment of paroxysmal sympathetic storm with labetalol. J NeurolNeurosurg Psychiatry. 2000; 69:832-3. https://doi.org/10.1136/jnnp.69.6.832
Molina PE. Neurobiology of the stress response: contribution of the sympathetic nervous system to theneuroimmune axis in traumatic injury. Shock. 2005; 24:3- https://doi.org/10.1097/01.shk.0000167112.18871.5c
Markus T, Hansson SR, Cronberg T, et al. β-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices. J Neuroinflammation. 2010; 20(7):94. https://doi.org/10.1186/1742-2094-7-94
Wang J, Li J, Sheng X, et al. Adrenoceptor mediated surgery-induced production of proinflammatory cytokines in rat microglia cells. J Neuroimmunol.2010; 223(1-2):77-83. https://doi.org/10.1016/j.jneuroim.2010.04.006
Kato H, Kawaguchi M, Inoue S, et al. The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats. AnesthAnalg. 2009; 108(1):288-95. https://doi.org/10.1213/ane.0b013e318187bb93
Goyagi T, Kimura T, Nishikawa T, et al. Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats. AnesthAnalg. 2006;103: 658-663. https://doi.org/10.1213/01.ane.0000228859.95126.69
Mantyh PW, Rogers SD, Allen CJ, et al. Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J Neurosci. 1995; 15: 152-164. https://doi.org/10.1523/JNEUROSCI.15-01-00152.1995
Khalili H, Ah R, Paydar S, et al. Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial. World J Surg. 2020; 44:1844-1853. https://doi.org/10.1007/s00268-020-05391-8
Ammar MA, Hussein NS. Using propranolol in traumatic brain injury to reduce sympathetic storm phenomenon: A prospective randomized clinical trial.Saudi J Anaesth. 2018; 12(4):514-520. 10.4103/sja.SJA_33_18
Nordstrom CH, Messeter K, Sundbarg G, et al. Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions. J Neurosurg. 1988; 68: 424-431. https://doi.org/10.3171/jns.1988.68.3.0424
Asgeirsson B, Grände PO, Nordström CH, et al. Effects of hypotensive treatment with alpha 2-agonist and beta 1-antagonist on cerebral haemodynamics in severely head injured patients. ActaAnaesthesiol Scand. 1995; 39: 347-351. https://doi.org/10.1111/j.1399-6576.1995.tb04075.x
Eker C, Asgeirsson B, Grande PO, et al. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med.1998; 26:1881-1886. https://doi.org/10.1097/00003246-199811000-00033
Gisvold SE. The Lund concept for treatment of head injuries- faith or science? ActaAnaesthesiol Scand. 2001; 45:399-40. https://doi.org/10.1034/j.1399-6576.2001.045004399.x
Wahlstrom MR, Olivecrona M, Koskinen LO, et al. Severe traumatic brain injury in pediatric patients: treatment and outcome using an intracranial pressure targeted therapy-the Lund concept. Intensive Care Med. 2005; 31:832-839. https://doi.org/10.1007/s00134-005-2632-2
Tran TY, Dunne IE, German JW, et al. Beta blockers exposure and traumatic brain injury: a literature review. Neurosurg Focus. 2008;25(4): E8. https://doi.org/10.3171/FOC.2008.25.10.E8
GhajarJ. Traumatic brain injury. Lancet. 2000; 356 (9233):923-929. https://doi.org/10.1016/S0140-6736(00)02689-1
Murry JS, Hoang DM, Barmparas G, et al. Prospectiveevaluation of early propranolol after traumatic brain injury. J Surg Res.2016; 200(1):221-226. https://doi.org/10.1016/j.jss.2015.06.045
Cruickshank JM, Degaute JP, Kuurne T, etal.Reductionofstress/catecholamine-induced cardiac necrosis by beta1-selectiveblockade. Lancet. 1987; 2(8559):585-589. https://doi.org/10.1016/S0140-6736(87)92984-9
Garg M, Garg K, Singh PK, et al. Neurogenic Fever in Severe Traumatic Brain Injury Treated with Propranolol: A Case Report. Neurol India. 2019; 67(4):1097-1099. https://doi.org/10.4103/0028-3886.266258
Meythaler JM, Stinson AM. Fever of central origin in traumatic brain injury controlled with propranolol. Arch Phys Med Rehabil. 1994; 75:816-8. https://doi.org/10.1016/0003-9993(94)90143-0
Sazbon L, Groswasser Z. Outcome in 134 patients with prolonged posttraumatic unawareness. Part 1: Parameters determining late recovery of consciousness. J Neurosurg. 1990; 72:75-80. https://doi.org/10.3171/jns.1990.72.1.0075
Published
Abstract Display: 519 
PDF Downloads: 625 PDF Downloads: 119 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.